Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Hindu
The Hindu
National
Bindu Shajan Perappadan

Gambia cough syrup-related deaths | CDSCO to examine Maiden Pharma’s role, Haryana sends notice to firm

Union Health Ministry’s Central Drugs Standard Control Organisation (CDSCO) said, on Wednesday, that it will examine the response of Haryana-based Maiden Pharmaceuticals Limited to allegations of serious violations of norms set for the production of drugs by the Haryana State Drugs Controller.

Haryana Health Minister Anil Vij told ANI that authorities inspected a Maiden factory in the town of Sonepat in the State and found 12 violations of good practices. Production was ordered stopped, Mr. Vij said.

The State Drugs Controller-Cum-Licensing Authority, Department of Food & Drugs Administration, Haryana, issued the notice under the rule 85(2) of Drugs and Cosmetics Act, 1940 and Rules, 1945 to Maiden Pharma asking as to why the firm’s manufacturing license should not be suspended/cancelled since many contraventions were found during inspection.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.